Zantac FAQs

Before the FDA’s recall of all medication containing ranitidine, Zantac used to be the primary choice for heartburn medication in the U.S. Although Zantac has not disappeared off the market yet, it is widely established that regular Zantac users should stop consuming any medication containing traces of NDMA (a substance that could cause cancer, frequently found in ranitidine). The FDA is aggressively and actively fighting for the complete removal of such drugs from the U.S. market.

Future restrictions will imply that consumers won’t be able to purchase any ranitidine medication over-the-counter or through prescription. Over 500 Zantac lawsuits have been filed subsequent to FDA’s recall, as many cancer types were linked to Zantac consumption, including the following:

• Liver cancer
• Ovarian cancer
• Breast cancer
• Stomach cancer
• Melanoma
• Prostate cancer

Zantac users diagnosed with cancer may be entitled to financial compensation for their medical expenses. Learn more about the ongoing Zantac recall case in John Foy & Associates FAQs. If you or a loved one have been diagnosed with cancer after consistent consumption of ranitidine, call John Foy today for legal guidance and read our FAQs.